The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Engineered CRISPR-Cas9 nucleases with altered PAM specificities
Open accessAbstract
Although CRISPR-Cas9 nucleases are widely used for genome editing, the range of sequences that Cas9 can recognize is constrained by the need for a specific protospacer adjacent motif (PAM). As a result, it can often be difficult to target double-stranded breaks (DSBs) with the precision that is necessary for various genome-editing applications. The ability to engineer Cas9 derivatives with purposefully altered PAM specificities would address this limitation. Here we show that the commonly used Streptococcus pyogenes Cas9 (SpCas9) can be modified to recognize alternative PAM sequences using structural information, bacterial selection-based directed evolution, and combinatorial design. These altered PAM specificity variants enable robust editing of endogenous gene sites in zebrafish and human cells not currently targetable by wild-type SpCas9, and their genome-wide specificities are comparable to wild-type SpCas9 as judged by GUIDE-seq analysis. In addition, we identify and characterize another SpCas9 variant that exhibits improved specificity in human cells, possessing better discrimination against off-target sites with non-canonical NAG and NGA PAMs and/or mismatched spacers. We also find that two smaller-size Cas9 orthologues, Streptococcus thermophilus Cas9 (St1Cas9) and Staphylococcus aureus Cas9 (SaCas9), function efficiently in the bacterial selection systems and in human cells, suggesting that our engineering strategies could be extended to Cas9s from other species. Our findings provide broadly useful SpCas9 variants and, more importantly, establish the feasibility of engineering a wide range of Cas9s with altered and improved PAM specificities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Precision editing of alleles in a human cell has drastically improved the understanding of genotypic and phenotypic effects in gene therapy due to the lower off-target rates [119,120,121].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [120]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Besides, there are other variants that could identify different PAM sequences, such as VQR, VRER, VRQR, and QQR1, allowing gene editing on a wider range of genetic loci.”
From Machine learning-based prediction models to guide the selection of Cas9 variants for efficient gene editing (2024) · cites this paper as [25]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The basic bacterial selection scheme performed was adapted from a previously described positive selection system for identifying Cas9 mutants in E. coli31.”
From A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells (2018) · cites this paper as [31]
The cited source says what the claim attributes to it.
In the citing paper
“To be applicable to a wider range of genomic sites, some non-NGG PAM Cas9 were generated.”
From Machine learning-based prediction models to guide the selection of Cas9 variants for efficient gene editing (2024) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“This could result in the development of wider-ranged VQR, EQR, and VRER SpCas9 variants, enabling the targeting of NGAN, NGNG, and NGCG PAMs, respectively (Kleinstiver et al., 2015; Hirano et al., 2016).”
From Emerging applications of gene editing technologies for the development of climate-resilient crops (2025) · cites this paper as Kleinstiver et al., 2015
The cited source says what the claim attributes to it.
In the citing paper
“These modifications have led to the creation of SpCas9 variants such as VQR, EQR, and VRER, which can recognize broader PAM sequences like NGAN, NGNG, and NGCG, respectively (Kleinstiver et al., 2015; Hirano et al., 2016).”
From Emerging applications of gene editing technologies for the development of climate-resilient crops (2025) · cites this paper as Kleinstiver et al., 2015
The cited source says what the claim attributes to it.
In the citing paper
“Cas9 genomic localization is delimited by the protospacer adjacent motif (PAM), which is NGG for SpCas9 while evolved variants of SpCas9 tolerate a broader range of PAM sequences17–21.”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [18]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“This screen identified four key beneficial point mutations in SpCas9, giving rise to evoCas9, a variant that exhibits fidelity exceeding SpCas9-HF1 and eSpCas9 (Kleinstiver et al., 2015; Casini et al., 2018).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Kleinstiver et al., 2015
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“SaKKHcas9 is an evolved variant of SaCas9 and recognizes the more relaxed NNNRRT PAM18.”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [18]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
The new frontier of genome engineering with CRISPR-Cas9
Doudna, J. A., & Charpentier, E. (2014) · Science · doi:10.1126/science.1258096 · Cited by 7,062
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299
High-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292
Self-citationCRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 1,001
CRISPR–Cas9 in genome editing: Its function and medical applications
Khadempar, S., Familghadakchi, S., Motlagh, R. A., Farahani, N., Dashtiahangar, M., Rezaei, H., & Hayat, S. M. G. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27476 · Cited by 53
CRISPR base editing and prime editing: DSB and template-free editing systems for bacteria and plants
Abdullah, A., Jiang, Z., Hong, X., Zhang, S., Yao, R., & Xiao, Y. (2020) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2020.08.003 · Cited by 52
Lampert, A., Bennett, D., McDermott, L., Neureiter, A., Eberhardt, E., Winner, B., & Zenke, M. (2020) · Neurobiology of Pain · doi:10.1016/j.ynpai.2020.100055 · Cited by 53
Genome dependent Cas9/gRNA search time underlies sequence dependent gRNA activity
Moreb, E. A., & Lynch, M. (2021) · Nature Communications · doi:10.1038/s41467-021-25339-3 · Cited by 53
Compendium of Plant-Specific CRISPR Vectors and Their Technical Advantages
Alok, A., Chauhan, H., Upadhyay, S. K., Pandey, A. K., Kumar, J., & Singh, K. (2021) · Life · doi:10.3390/life11101021 · Cited by 51
Recent advances in CRISPR‐based systems for the detection of foodborne pathogens
Shin, J., Miller, M. J., & Wang, Y. (2022) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12956 · Cited by 51
Insights into the Mechanism of CRISPR/Cas9-Based Genome Editing from Molecular Dynamics Simulations
Bhattacharya, S., & Satpati, P. (2022) · ACS Omega · doi:10.1021/acsomega.2c05583 · Cited by 51
Sun, L., Alariqi, M., Wang, Y., Wang, Q., Xu, Z., Zafar, M. N., Yang, G., Jia, R., Hussain, A., Chen, Y., et al. (2023) · Advanced Science · doi:10.1002/advs.202306157 · Cited by 52
CRISPRz: a database of zebrafish validated sgRNAs
Varshney, G. K., Zhang, S., Pei, W., Adomako‐Ankomah, A., Fohtung, J., Schaffer, K. E., Carrington, B., Maskeri, A., Slevin, C. C., Wolfsberg, T. G., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv998 · Cited by 50
Shao, S., Chang, L., Sun, Y., Hou, Y., Fan, X., & Sun, Y. (2017) · ACS Synthetic Biology · doi:10.1021/acssynbio.7b00268 · Cited by 50
Cutting Edge Genetics: CRISPR/Cas9 Editing of Plant Genomes
Soyars, C. L., Peterson, B. A., Burr, C. A., & Nimchuk, Z. L. (2018) · Plant and Cell Physiology · doi:10.1093/pcp/pcy079 · Cited by 50
Specific targeting of point mutations in EGFR L858R-positive lung cancer by CRISPR/Cas9
Cheung, A. H. K., Chow, C., Zhang, J., Zhou, Y., Huang, T., Ng, K. C.-K., Or, T. C. T., Yao, Y. Y., Dong, Y., Fung, J. M.-W., et al. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0056-1 · Cited by 50
Therapeutic Genome Editing in Cardiovascular Diseases
German, D. M., Mitalipov, S. M., Mishra, A., & Kaul, S. (2019) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2018.11.004 · Cited by 52
CRISPR-Cas System, a Possible “Savior” of Rice Threatened by Climate Change: An Updated Review
Shaheen, N., Ahmad, S., Alghamdi, S. S., Rehman, H. M., Javed, M. A., Tabassum, J., & Shao, G. (2023) · Rice · doi:10.1186/s12284-023-00652-1 · Cited by 49
Functional dissection of complex trait variants at single-nucleotide resolution
Siraj, L., Castro, R. I., Dewey, H. B., Kales, S., Butts, J. C., Nguyen, T. T. L., Kanai, M., Berenzy, D., Mouri, K., Wang, Q. S., et al. (2026) · Nature · doi:10.1038/s41586-026-10121-6 · Cited by 56
Wang, Q., Liu, S., Liu, Z., Ke, Z., Li, C., Yu, X., Chen, S., & Guo, D. (2018) · Virus Research · doi:10.1016/j.virusres.2018.04.002 · Cited by 49
Catalytic-state structure and engineering of Streptococcus thermophilus Cas9
Zhang, Y., Zhang, H., Xu, X., Wang, Y., Chen, W., Wang, Y., Wu, Z., Tang, N., Wang, Y., Zhao, S., et al. (2020) · Nature Catalysis · doi:10.1038/s41929-020-00506-9 · Cited by 49
Allele-specific editing ameliorates dominant retinitis pigmentosa in a transgenic mouse model
Patrizi, C., Llado-Santaeularia, M., Benati, D., Iodice, C., Marrocco, E., Guarascio, R., Surace, E. M., Cheetham, M. E., Auricchio, A., & Recchia, A. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.01.006 · Cited by 51
Specificity of oligonucleotide gene therapy (OGT) agents
Nedorezova, D. D., Dubovichenko, M. V., Belyaeva, E. P., Grigorieva, E. D., Peresadina, A. V., & Kolpashchikov, D. M. (2022) · Theranostics · doi:10.7150/thno.77830 · Cited by 50
New advances in CRISPR/Cas-mediated precise gene-editing techniques
Richardson, C., Kelsh, R. N., & Richardson, R. J. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.049874 · Cited by 48
Yan, W., Chen, D., & Kaufmann, K. (2016) · Plant Methods · doi:10.1186/s13007-016-0125-7 · Cited by 50
Genome engineering in ophthalmology: Application of CRISPR/Cas to the treatment of eye disease
Hung, S. S. C., McCaughey, T., Swann, O. G., Pébay, A., & Hewitt, A. W. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2016.05.001 · Cited by 49
Zhao, D., Xu, F., Zhu, X., Wu, T., Zhang, X., & Bi, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-16998-8 · Cited by 48
Engineering CRISPR/Cpf1 with tRNA promotes genome editing capability in mammalian systems
Wu, H., Liu, Q., Shi, H., Xie, J., Zhang, Q., Ouyang, Z., Li, N., Yang, Y., Liu, Z., Zhao, Y., et al. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2810-3 · Cited by 49
New Possibilities on the Horizon: Genome Editing Makes the Whole Genome Accessible for Changes
Kawall, K. (2019) · Frontiers in Plant Science · doi:10.3389/fpls.2019.00525 · Cited by 50
O’Brien, A. R., Wilson, L. O. W., Burgio, G., & Bauer, D. C. (2019) · Scientific Reports · doi:10.1038/s41598-019-39142-0 · Cited by 48
Monsur, M. B., Shao, G., Lv, Y., Ahmad, S., Wei, X., Hu, P., & Tang, S. (2020) · Genes · doi:10.3390/genes11040466 · Cited by 48
Gene Editing of Hematopoietic Stem Cells: Hopes and Hurdles Toward Clinical Translation
Ferrari, S., Vavassori, V., Canarutto, D., Jacob, A., Castiello, M. C., Omer, A., & Genovese, P. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.618378 · Cited by 52
CRISPR-Based Genome Editing: Advancements and Opportunities for Rice Improvement
Zegeye, W. A., Tsegaw, M., Zhang, Y., & Cao, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084454 · Cited by 49
Recent advancements in CRISPR/Cas technology for accelerated crop improvement
Das, D., Singha, D. L., Paswan, R. R., Chowdhury, N., Sharma, M., Reddy, P. S., & Chikkaputtaiah, C. (2022) · Planta · doi:10.1007/s00425-022-03894-3 · Cited by 50
Continuous directed evolution of a compact CjCas9 variant with broad PAM compatibility
Schmidheini, L., Mathis, N., Marquart, K. F., Rothgangl, T., Kissling, L., Böck, D., Chanez, C., Wang, J. P., Jínek, M., & Schwank, G. (2023) · Nature Chemical Biology · doi:10.1038/s41589-023-01427-x · Cited by 49
Palacios, A. M., Korus, P., Wilkens, B. G. C., Heshmatpour, N., & Patnaik, S. R. (2024) · Frontiers in Genome Editing · doi:10.3389/fgeed.2024.1342193 · Cited by 49
Generating Mouse Models Using CRISPR‐Cas9‐Mediated Genome Editing
Qin, W., Kutny, P. M., Maser, R. S., Dion, S., Lamont, J. D., Zhang, Y., Perry, G. A., & Wang, H. (2016) · Current Protocols in Mouse Biology · doi:10.1002/9780470942390.mo150178 · Cited by 47
Raitskin, O., Schudoma, C., West, A., & Patron, N. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211598 · Cited by 50
Efficient base editing with high precision in rabbits using YFE-BE4max
Liu, Z., Chen, S., Shan, H., Jia, Y., Chen, M., Song, Y., Lai, L., & Li, Z. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2244-3 · Cited by 47
Self-citationCRISPR-based enrichment strategies for targeted sequencing
Schultzhaus, Z. S., Wang, Z., & Stenger, D. A. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2020.107672 · Cited by 47
Nair, V. P., Liu, H., Ciceri, G., Jungverdorben, J., Frishman, G., Tchieu, J. H., Cederquist, G., Rothenaigner, I., Schorpp, K., Klepper, L., et al. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.04.009 · Cited by 50
Moving toward genome-editing therapies for cardiovascular diseases
Musunuru, K. (2022) · Journal of Clinical Investigation · doi:10.1172/jci148555 · Cited by 48
Identification of biomarkers and genetic approaches toward chronic obstructive pulmonary disease
Wadhwa, R., Aggarwal, T., Malyla, V., Kumar, N., Gupta, G., Chellappan, D. K., Dureja, H., Mehta, M., Satija, S., Gulati, M., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28482 · Cited by 46
CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool
Baghini, S. S., Gardanova, Z. R., Abadi, S. A. H., Zaman, B. A., İlhan, A., Shomali, N., Adili, A., Moghaddar, R., & Yaseri, A. F. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00336-6 · Cited by 46
Li, C., Du, Y., Zhang, T., Wang, H., Hou, Z., Zhang, Y., Cui, W., & Chen, W. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.09.026 · Cited by 48
Application progress of CRISPR/Cas9 genome-editing technology in edible fungi
Zhang, Y., Chen, S., Yang, L., & Zhang, Q. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1169884 · Cited by 48
CRISPR/Cas9: A Practical Approach in Date Palm Genome Editing
Sattar, M. N., Iqbal, Z., Tahir, M. N., Shahid, M. S., Khurshid, M., Al-Khateeb, A. A., & Al-Khateeb, S. A. (2017) · Frontiers in Plant Science · doi:10.3389/fpls.2017.01469 · Cited by 47
Deactivated CRISPR Associated Protein 9 for Minor-Allele Enrichment in Cell-Free DNA
Aalipour, A., Dudley, J. C., Park, S.-M., Murty, S., Chabon, J. J., Boyle, E. A., Diehn, M., & Gambhir, S. S. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2017.278911 · Cited by 48
Potential impact of genome editing in world agriculture
Martínez-Fortún, J., Phillips, D. W., & Jones, H. D. (2017) · Emerging Topics in Life Sciences · doi:10.1042/etls20170010 · Cited by 46
Multimode drug inducible CRISPR/Cas9 devices for transcriptional activation and genome editing
Lu, J. Q., Zhao, C., Zhao, Y., Zhang, J., Zhang, Y., Chen, L., Han, Q., Yue, Y., Peng, S., Ai, R., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1222 · Cited by 46
Programmable Molecular Scissors: Applications of a New Tool for Genome Editing in Biotech
Saha, S. K., Saikot, F. K., Rahman, M. S., Jamal, M. A. H. M., Rahman, S. M. K., Islam, S. M. R., & Kim, K. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.11.016 · Cited by 48
Bruntraeger, M., Byrne, M. L., Long, K. R., & Bassett, A. R. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9170-9_11 · Cited by 49
Raikwar, S. P., Kikkeri, N. S., Sakuru, R. C., Saeed, D., Zahoor, H., Premkumar, K., Mentor, S., Thangavel, R., Dubova, I., Ahmed, M. E., et al. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09849-y · Cited by 48
Dandage, R., Després, P. C., Yachie, N., & Landry, C. R. (2019) · Genetics · doi:10.1534/genetics.119.302089 · Cited by 46
Ocular delivery of CRISPR/Cas genome editing components for treatment of eye diseases
Yu, W., & Wu, Z. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.011 · Cited by 48
Genome editing in animals with minimal PAM CRISPR-Cas9 enzymes
Vicencio, J., Sánchez-Bolaños, C., Moreno-Sánchez, I., Brena, D., Vejnar, C. E., Kukhtar, D., Ruiz-López, M., Cots-Ponjoan, M., Rubio, A., Melero, N. R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30228-4 · Cited by 47
Self-citationScalable characterization of the PAM requirements of CRISPR–Cas enzymes using HT-PAMDA
Walton, R. T., Hsu, J. Y., Joung, J. K., & Kleinstiver, B. P. (2021) · Nature Protocols · doi:10.1038/s41596-020-00465-2 · Cited by 49
Self-citationStructure of the OMEGA nickase IsrB in complex with ωRNA and target DNA
Hirano, S., Kappel, K., Altae-Tran, H., Faure, G., Wilkinson, M. E., Kannan, S., Demircioglu, F. E., Yan, R., Shiozaki, M., Yu, Z., et al. (2022) · Nature · doi:10.1038/s41586-022-05324-6 · Cited by 45
An adenine base editor variant expands context compatibility
Xiao, Y., Wu, Y., & Tang, W. (2024) · Nature Biotechnology · doi:10.1038/s41587-023-01994-3 · Cited by 48
Improvements of TKC Technology Accelerate Isolation of Transgene-Free CRISPR/Cas9-Edited Rice Plants
He, Y., Min, Z., Lihao, W., Wu, J., Wang, Q., Wang, R., & Zhao, Y. (2019) · Rice Science · doi:10.1016/j.rsci.2018.11.001 · Cited by 46
CRISPR/Cas9-Mediated Gene Editing Revolutionizes the Improvement of Horticulture Food Crops
Wang, T., Zhang, C., Zhang, H., & Zhu, H. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c00104 · Cited by 45
PAM-flexible Engineered FnCas9 variants for robust and ultra-precise genome editing and diagnostics
Acharya, S., Ansari, A. H., Das, P. K., Hirano, S., Aich, M., Rauthan, R., Mahato, S., Maddileti, S., Sarkar, S., Kumar, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49233-w · Cited by 47
Genome editing in zebrafish: a practical overview
Sertori, R., Trengove, M. C., Basheer, F., Ward, A. C., & Liongue, C. (2015) · Briefings in Functional Genomics · doi:10.1093/bfgp/elv051 · Cited by 44
Krapivinsky, G. B., Krapivinsky, L., Renthal, N. E., Santa‐Cruz, A., Manasian, Y., & Clapham, D. E. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1708427114 · Cited by 45
Nadakuduti, S. S., Starker, C. G., Ko, D. K., Jayakody, T. B., Buell, C. R., Voytas, D. F., & Douches, D. S. (2019) · Frontiers in Plant Science · doi:10.3389/fpls.2019.00110 · Cited by 44
FrCas9 is a CRISPR/Cas9 system with high editing efficiency and fidelity
Cui, Z., Tian, R., Huang, Z., Jin, Z., Li, L., Liu, J., Huang, Z., Xie, H., Liu, D., Mo, H., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29089-8 · Cited by 46
Mitochondrial genome engineering coming-of-age
Barrera-Paez, J. D., & Moraes, C. T. (2022) · Trends in Genetics · doi:10.1016/j.tig.2022.04.011 · Cited by 44
Emerging applications of gene editing technologies for the development of climate-resilient crops
Chavhan, R. L., Jaybhaye, S. G., Hinge, V. R., Deshmukh, A. S., Shaikh, U. S., Jadhav, P. K., Kadam, U. S., & Hong, J. C. (2025) · Frontiers in Genome Editing · doi:10.3389/fgeed.2025.1524767 · Cited by 55
Off-target effects of base editors: what we know and how we can reduce it
Slesarenko, Y. S., Лавров, А. В., & Smirnikhina, S. (2021) · Current Genetics · doi:10.1007/s00294-021-01211-1 · Cited by 45
The progress of molecules and strategies for the treatment of HBV infection
Pan, Y., Xia, H., He, Y., Zeng, S., Shen, Z., & Huang, W. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1128807 · Cited by 46
CRISPR/Cas9: at the cutting edge of hepatology
Pankowicz, F. P., Jarrett, K. E., Lagor, W. R., & Bissig, K. (2017) · Gut · doi:10.1136/gutjnl-2016-313565 · Cited by 43
Inheritance of co-edited genes by CRISPR-based targeted nucleotide substitutions in rice
Shimatani, Z., Fujikura, U., Ishii, H., Matsui, Y., Suzuki, M., Ueke, Y., Taoka, K.-I., Terada, R., Nishida, K., & Kondo, A. (2018) · Plant Physiology and Biochemistry · doi:10.1016/j.plaphy.2018.04.028 · Cited by 44
A programmable high-expression yeast platform responsive to user-defined signals
Liu, Q., Song, L., Peng, Q., Zhu, Q., Shi, X., Xu, M.-Q., Wang, Q., Zhang, Y., & Cai, M. (2022) · Science Advances · doi:10.1126/sciadv.abl5166 · Cited by 43
Rational design of a compact CRISPR-Cas9 activator for AAV-mediated delivery
Vora, S., Cheng, J., Xiao, R., VanDusen, N. J., Quintino, L., Pu, W. T., Vandenberghe, L. H., Chavez, A., & Church, G. (2018) · doi:10.1101/298620 · Cited by 42
Sattar, M. N., Iqbal, Z., Al-Khayri, J. M., & Jain, S. M. (2021) · Plants · doi:10.3390/plants10071347 · Cited by 45
Thean, D., Chu, H. Y., Fong, J. H. C., Chan, B. K. C., Zhou, P., Kwok, C. C. S., Chan, Y. M., Mak, S. Y. L., Choi, G. C. G., Ho, J. W. K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29874-5 · Cited by 44
Self-citationAltered DNA repair pathway engagement by engineered CRISPR-Cas9 nucleases
Chauhan, V. P., Sharp, P. A., & Langer, R. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2300605120 · Cited by 43
Opportunities and Challenges of In Vitro Tissue Culture Systems in the Era of Crop Genome Editing
Bekalu, Z. E., Panting, M., Holme, I. B., & Brinch‐Pedersen, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241511920 · Cited by 43
Li, J., Wiesinger, A., Fokkert, L., Bakker, P., de Vries, D. K., Tijsen, A. J., Pinto, Y. M., Verkerk, A. O., Christoffels, V. M., Boink, G. J. J., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.08.008 · Cited by 42
Alariqi, M., Ramadan, M., Yu, L., Hui, F., Hussain, A., Zhou, X., Yu, Y., Zhang, X., & Jin, S. (2025) · Advanced Science · doi:10.1002/advs.202416331 · Cited by 42
CRISPR/Cas9- loxP -Mediated Gene Editing as a Novel Site-Specific Genetic Manipulation Tool
Yang, F., Liu, C., Chen, D., Tu, M., Xie, H., Sun, H., Ge, X., Tang, L., Li, J., Zheng, J., et al. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.04.018 · Cited by 44
Fusion guide RNAs for orthogonal gene manipulation with Cas9 and Cpf1
Kweon, J., Jang, A.-H., Kim, D., Yang, J. W., Yoon, M.-J., Shin, H. R., Kim, J., & Kim, Y. (2017) · Nature Communications · doi:10.1038/s41467-017-01650-w · Cited by 43
New tools for old drugs: Functional genetic screens to optimize current chemotherapy
Gerhards, N. M., & Rottenberg, S. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.01.001 · Cited by 43
CRISPR RNA-guided autonomous delivery of Cas9
Wilkinson, R. A., Martin, C. D., Nemudryi, A. A., & Wiedenheft, B. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0173-y · Cited by 43
Wu, Y. C., Xu, W., Wang, F., Zhao, S., Feng, F., Song, J., Zhang, C., & Yang, J. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00379 · Cited by 45
Yamamoto, A., Ishida, T., Yoshimura, M., Kimura, Y., & Sawa, S. (2019) · Plant and Cell Physiology · doi:10.1093/pcp/pcz118 · Cited by 42
Yin, H., Yuan, X., Luo, L., Lu, Y., Qin, B., Zhang, J., Shi, Y., Zhu, C., Yang, J., Li, X., et al. (2020) · Advanced Science · doi:10.1002/advs.201903381 · Cited by 42
Minimizing off-Target Mutagenesis Risks Caused by Programmable Nucleases
Ishida, K., Gee, P., & Hotta, A. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161024751 · Cited by 41
Genome engineering: Drosophila melanogaster and beyond
Venken, K. J. T., Sarrion‐Perdigones, A., Vandeventer, P. J., Abel, N. S., Christiansen, A. E., & Hoffman, K. L. (2015) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.214 · Cited by 43
Rubio, A., Luoni, M., Giannelli, S. G., Radice, I., Iannielli, A., Cancellieri, C., Berardino, C. D., Regalia, G., Lazzari, G., Menegon, A., et al. (2016) · Scientific Reports · doi:10.1038/srep37540 · Cited by 41
Efficient genome editing using CRISPR/Cas9 ribonucleoprotein approach in cultured medaka fish cells
Liu, Q., Yuan, Y., Zhu, F., Hong, Y., & Ge, R. (2018) · Biology Open · doi:10.1242/bio.035170 · Cited by 41
Wide Horizons of CRISPR-Cas-Derived Technologies for Basic Biology, Agriculture, and Medicine
Molla, K. A., Karmakar, S., & Islam, T. (2020) · Springer protocols handbooks/Springer protocols · doi:10.1007/978-1-0716-0616-2_1 · Cited by 42
Regulating CRISPR/Cas9 Function through Conditional Guide RNA Control
Brown, W., Zhou, W., & Deiters, A. (2020) · ChemBioChem · doi:10.1002/cbic.202000423 · Cited by 42
Structure of the type V-C CRISPR-Cas effector enzyme
Kurihara, N., Nakagawa, R., Hirano, H., Okazaki, S., Tomita, A., Kobayashi, K., Kusakizako, T., Nishizawa, T., Yamashita, K., Scott, D. A., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.03.006 · Cited by 42
GUIDEseq: a bioconductor package to analyze GUIDE-Seq datasets for CRISPR-Cas nucleases
Zhu, L. J., Lawrence, M., Gupta, A., Pagès, H., Küçükural, A., Garber, M. G., & Wolfe, S. A. (2017) · BMC Genomics · doi:10.1186/s12864-017-3746-y · Cited by 42
CRISPR/Cas9 technology and its application in horticultural crops
Liu, Y., Zhang, C., Wang, X., Li, X., & You, C. (2022) · Horticultural Plant Journal · doi:10.1016/j.hpj.2022.04.007 · Cited by 41
Kurzawa‐Akanbi, M., Tzoumas, N., Corral-Serrano, J. C., Guarascio, R., STEEL, D. H., Cheetham, M. E., Armstrong, L., & Lako, M. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101248 · Cited by 41
Engineered prime editors with minimal genomic errors
Chauhan, V. P., Sharp, P. A., & Langer, R. (2025) · Nature · doi:10.1038/s41586-025-09537-3 · Cited by 44
Ma, S., Liu, Y., Liu, Y., Chang, J., Zhang, T., Wang, X., Shi, R., Lü, W., Xia, X., Zhao, P., et al. (2017) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2017.02.003 · Cited by 40
Feng, Y.-L., Liu, S., Chen, R.-D., & Xie, A. (2021) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2000282 · Cited by 42
A more efficient CRISPR-Cas12a variant derived from Lachnospiraceae bacterium MA2020
Tran, M. H., Park, H., Nobles, C. L., Karunadharma, P. P., Pan, L., Zhong, G., Wang, H., He, W., Ou, T., Crynen, G. C., et al. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.02.012 · Cited by 41
Rittiner, J. E., Cumaran, M., Malhotra, S., & Kantor, B. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1035543 · Cited by 42
A most formidable arsenal: genetic technologies for building a better mousePreprint
Clark, J. F., Dinsmore, C. J., & Soriano, P. M. (2020) · Genes & Development · doi:10.1101/gad.342089.120 · Cited by 40
The Mechanisms of Genome Editing Technologies in Crop Plants
Ahmad, Y., Haider, S., Iqbal, J., Abbasi, B. A., Yaseen, T., & Mahmood, T. (2022) · Springer eBooks · doi:10.1007/978-3-030-96925-7_13 · Cited by 40
Metadata
- Authors
- Kleinstiver, B. P., Prew, M. S., Tsai, S. Q., Topkar, V. V., Nguyen, N. T., Zheng, Z., Gonzales, A. P. W., Li, Z., Peterson, R. T., Yeh, J.-R. J., Aryee, M. J., & Joung, J. K.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Broad Institute (US)
- Corresponding author
- Joung, J. Keith
- ORCID
- Venue
- Nature
- Published
- 2015-06-22
- Volume
- 523
- Issue
- 7561
- Pages
- 481-485
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4540238
- OpenAlex
- W4245053291
- Semantic Scholar
- afe29e1767b5d0f3563ee9f2c1a586a9d5e8cb9b
- Cited by
- 1,624
- References
- 36
- Citations by year
- 2026: 58 · 2025: 105 · 2024: 117 · 2023: 134 · 2022: 166 · 2021: 165 · 2020: 164 · 2019: 154 · 2018: 147 · 2017: 186 · 2016: 167 · 2015: 58
- FWCI
- 80.95
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institute of General Medical Sciences (DP1GM105378, R01GM107427, R01GM088040)
- National Center for Chronic Disease Prevention and Health Promotion (DP1 GM105378)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- Keywords
- CRISPR/Cas9, SpCas9, protospacer adjacent motif, genome editing, off-target effects, SaCas9, Cas9 nickase, zebrafish
- MeSH terms
- Animals, Cell Line, Humans, Mutation, Staphylococcus aureus, Streptococcus pyogenes, Substrate Specificity, Zebrafish, Protein Engineering, Genome, Directed Molecular Evolution, Amino Acid Substitution, Streptococcus thermophilus, Nucleotide Motifs, Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR-Cas Systems, CRISPR-Associated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
